Adaptive Biotechnologies (ADPT) Other Working Capital Changes (2018 - 2026)

Adaptive Biotechnologies has reported Other Working Capital Changes for 9 years, with the latest figure at $4.0 million in Q1 2026.

• Quarterly Other Working Capital Changes rose 66633.33% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 16865.22% YoY) and the FY2025 annual result came in at -$142000.0, down 425.93% from the prior year.
• Other Working Capital Changes eased to $4.0 million in Q1 2026 per ADPT's latest filing, from $40.3 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $4.3 million in Q3 2023 and troughed at -$2.9 million in Q4 2022.
• A 5-year average of $50176.5 and a median of $43000.0 in 2022 frame the typical range for Other Working Capital Changes.
• The widest YoY moves for Other Working Capital Changes: up 805300.0% in 2025, down 1832.29% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$56.3 million in 2022, then jumped by 141.28% to $23.3 million in 2023, then sank by 100.02% to -$5000.0 in 2024, then jumped by 805300.0% to $40.3 million in 2025, then sank by 90.05% to $4.0 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $4.0 million, $40.3 million, and -$40.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.